ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

NIH Authorization Bills Require NCI To Spend 10% On Cancer control

February 12, 1993

Virus Program Scientific Activities Report Concluded

August 22, 1975

Wittes, Group Chairmen Agree On Payment Per Case, Other Methods To Increase Patient Accrual

August 21, 1987

Fisher Says Forget Grants-Contract Argument; What’s Needed Is More Flexibility

April 13, 1979

NCI, Litton Open Talks On Frederick Contract

February 6, 1976

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005